Researchers at Texas A&M Health have identified a molecular mechanism that increases cholesterol levels inside prostate ...
This may not apply in your husband’s case, but it’s worth having the conversation. The two meds Goldstein prescribes for men are flibanserin (Addyi), an oral tablet taken d ...
While sales of Talzenna, which Pfizer acquired in a $14 billion deal, have been “negligible” so far, the new results should ...
I’m sure I enjoyed them as a child, though my brain has not retained a single memory of any birthday from my youth. I do, however, have a cherished photo of my father and I — taken, it seems, moments ...
Pfizer (PFE) stock is in focus as Xtandi, marketed with Astellas (ALPMF), and cancer drug Talzenna succeed in a Phase 3 trial for prostate cancer. Read more here.
State data from 2018 through 2022 shows prostate cancer is the leading cancer diagnosis in Cuyahoga County, yet 77% of cases were caught early — above the statewide rate of 69%.
Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting patient impact. At the 2026 ASCO GU meeting, experts gathered to share the ...
Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow ...
Researchers presented clinical study results on the dual-tracer PET imaging technique at the European urology conference with peer-reviewed publication forthcoming.
Made famous by bush poet Banjo Paterson and immortalised on screen, The Man from Snowy River has long symbolised Australian resilience and ...
After exciting clinical trial results, Bell Potter has maintained its rating on this exciting ASX healthcare stock.
HIGHLIGHTSOral presentation on key results from the Co-PSMA (NCT06907641)[1] Investigator-Initiated Trial (IIT) was delivered by Prof Louise Emmett (St Vincent's Hospital Sydney) at the European ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results